Literature DB >> 4076843

Detection of abnormal platelet functions with an in vitro model of primary haemostasis.

M A Kratzer, S Bellucci, J P Caen.   

Abstract

A new technique, which simulates primary haemostasis in vitro was tested using blood from control persons and from patients with a defined abnormality of primary haemostasis. The device allows the reproducible measurement of in vitro bleeding time and volume in small samples of whole blood. Inhibition of platelet adhesion and aggregation can very sensitively be detected with the new technique, which allows its possible use in clinical or pharmacological applications.

Entities:  

Mesh:

Year:  1985        PMID: 4076843     DOI: 10.1159/000215174

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  4 in total

1.  In vitro bleeding test--a sensitive method for the detection of platelet function impairment and a potential test for the control of low-dose aspirin efficacy.

Authors:  V Kretschmer; B Schikor; D Soehngen; G Dietrich
Journal:  Blut       Date:  1989-08

2.  Clinical application of a new in vitro bleeding time device on surgical patients.

Authors:  T Tsujinaka; T Itoh; Y Uemura; M Sakon; J Kambayashi; T Mori
Journal:  Jpn J Surg       Date:  1988-07

3.  Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.

Authors:  E V Negrescu; B Grünberg; M A Kratzer; R Lorenz; W Siess
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

4.  Effect of Clostridium perfringens β-Toxin on Platelets.

Authors:  Anne Thiel; Helga Mogel; Julia Bruggisser; Arnaud Baumann; Marianne Wyder; Michael H Stoffel; Artur Summerfield; Horst Posthaus
Journal:  Toxins (Basel)       Date:  2017-10-24       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.